Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
155.55
-2.51 (-1.59%)
At close: Mar 28, 2025, 4:00 PM
154.36
-1.19 (-0.77%)
Pre-market: Mar 31, 2025, 7:53 AM EDT
CRL Market Cap
CRL has a market cap or net worth of $7.96 billion as of March 31, 2025. Its market cap has decreased by -40.68% in one year.
Market Cap
7.96B
Enterprise Value
10.54B
1-Year Change
-40.68%
Ranking
Category
Stock Price
$155.55
Market Cap Chart
Since June 23, 2000, CRL's market cap has increased from $226.30M to $7.96B, an increase of 3,415.28%. That is a compound annual growth rate of 15.45%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 28, 2025 | 7.96B | -15.73% |
Dec 31, 2024 | 9.44B | -22.16% |
Dec 29, 2023 | 12.13B | 9.38% |
Dec 30, 2022 | 11.09B | -41.69% |
Dec 31, 2021 | 19.01B | 52.98% |
Dec 31, 2020 | 12.43B | 66.59% |
Dec 31, 2019 | 7.46B | 37.05% |
Dec 31, 2018 | 5.44B | 5.01% |
Dec 29, 2017 | 5.18B | 43.75% |
Dec 30, 2016 | 3.61B | -3.79% |
Dec 31, 2015 | 3.75B | 25.52% |
Dec 31, 2014 | 2.99B | 17.00% |
Dec 31, 2013 | 2.55B | 40.28% |
Dec 31, 2012 | 1.82B | 34.64% |
Dec 30, 2011 | 1.35B | -34.13% |
Dec 31, 2010 | 2.05B | -7.60% |
Dec 31, 2009 | 2.22B | 25.20% |
Dec 31, 2008 | 1.77B | -60.32% |
Dec 31, 2007 | 4.47B | 54.46% |
Dec 29, 2006 | 2.89B | -5.57% |
Dec 30, 2005 | 3.06B | 2.77% |
Dec 31, 2004 | 2.98B | 89.75% |
Dec 31, 2003 | 1.57B | -9.52% |
Dec 31, 2002 | 1.74B | 17.55% |
Dec 31, 2001 | 1.48B | 50.25% |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 738.61B |
UnitedHealth Group | 472.03B |
Johnson & Johnson | 394.52B |
AbbVie | 363.15B |
Novo Nordisk | 305.46B |
AstraZeneca | 229.16B |
Abbott Laboratories | 226.88B |
Merck & Co. | 225.40B |